NCT02963285 is a clinical trial of Nasopharyngeal temperature probe in Pediatric Temperature, sponsored by University of Texas Southwestern Medical Center.

Who is sponsoring NCT02963285?

NCT02963285 is sponsored by University of Texas Southwestern Medical Center.

What drugs are being tested in NCT02963285?

Interventions in NCT02963285: Nasopharyngeal temperature probe.

What condition does NCT02963285 study?

NCT02963285 studies Pediatric Temperature.

Is NCT02963285 still recruiting?

NCT02963285 is currently completed. Last updated 6 January 2022.

Last reviewed 2022-01-06 · How we verify

NCT02963285

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Optimal Positioning of Nasopharyngeal Temp Probe

Completed Last updated 6 January 2022

What this trial tests

trial testing Nasopharyngeal temperature probe in Pediatric Temperature in 158 participants. Completed in 3 August 2021.

Timeline

9 June 2017

Primary endpoint
2 December 2020

3 August 2021

Quick facts

Lead sponsor	University of Texas Southwestern Medical Center
Status	Completed
Study type	OBSERVATIONAL
Enrollment	158
Start date	9 June 2017
Primary completion	2 December 2020
Estimated completion	3 August 2021
Sites	1 location across United States

Drugs / interventions tested

Nasopharyngeal temperature probe

Conditions studied

Pediatric Temperature — all drugs for Pediatric Temperature →

Sponsor

University of Texas Southwestern Medical Center

Who can join

Adults 0 to 12, any sex, with Pediatric Temperature. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to determine the optimal range of insertion depths for a nasopharyngeal probe in anesthetized pediatric patients as a function of age.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University of Texas Southwestern Medical Center trials

Trials by the same sponsor.

NCT03849963 — Imaging Oxidative Metabolism and Neurotransmitter Synthesis in the Human Brain · recruiting
NCT06917183 — Developing Strategies for Implementation and Use of the Operating Room Black Box (ORBB) · NA · not yet recruiting
NCT05145309 — Value of Potassium Magnesium Citrate in Preventing and Treating Hypertension in African Americans · Phase 2 · not yet recruiting
NCT06552000 — Pre-operative Tumor Treating Fields in Patients With Resectable Lung Cancer · NA · not yet recruiting
NCT07387666 — Imaging Acetadote Metabolism in Glioblastoma · EARLY_PHASE1 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02963285 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Texas Southwestern Medical Center
Last refreshed: 6 January 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02963285.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing